Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128342) titled 'CGM Use in Non-insulin Patients With DM2' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Milwaukee VA Medical Center
Condition:
Diabetes
Type 2 Diabetes (T2DM)
Obesity Type 2 Diabetes Mellitus
Non Insulin Dependent Diabetes Mellitus
Intervention:
Device: CGM Group
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 1, 2025
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128342
Published by HT Di...